Skip to content

Arcus Biosciences RCUS Business Segments — Total Assets

Similar metrics at other companies

Concentra Group Holdings Parent logo
CONReportable Segment — Total Assets
$2.89B+5.9%
VGN
VGNTReportable Segment — Segment assets
$4.91B
PNW
PNWReportable Segment — Total Assets
$30.69B+12.7%
National Fuel Gas logo
NFGTotal Reportable Segments — Total Assets
$9.23B+8.0%
RXO logo
RXOReportable Segment — Total Assets
$3.17B-1.9%
Iron Mountain logo
IRMTOTAL REPORTABLE SEGMENTS — Total Assets
$19.22B+13.7%

Other financials

Income statement

See full
Revenue$17.0M-39.3%
Operating income-$134.0M-9.8%
Net income-$128.0M-14.3%
EPS (diluted)-$1.02+10.5%

Balance sheet

See full
Cash & equivalents$201.0M+4.7%
Total debt$113.0M+88.3%
Total equity$524.0M-1.3%
Total assets$997.0M-13.8%

Cash flow

See full
Operating cash flow-$138.0M-4.5%
CapEx--100%
Free cash flow-$138.0M-3.8%

Valuation

See full
Market cap$3.54B+226%
Enterprise value$3.46B+275%
P/S15×+7.3×

Profitability

See full
Operating margin-168.6%-52.7pp
Net margin-156.4%-47.5pp
FCF margin-207.2%

Returns & leverage

See full
Return on equity-70%+8.4pp
Debt / equity0.2×+0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's business segments — total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcus Biosciences's business segments — total assets?
Arcus Biosciences (RCUS) reported business segments — total assets of $1B in Q1 2026.
How has Arcus Biosciences's business segments — total assets changed year-over-year?
Arcus Biosciences's business segments — total assets decreased by 16.7% year-over-year, from $1.2B to $1B.
What does business segments — total assets mean?
Represents the total value of resources, including cash, equipment, and intellectual property, controlled by the segment. This metric provides a snapshot of the capital base available to support ongoing research and development initiatives.